Abiopharma

🔍 Hughes Owen (Executive)

Company: XOMA Royalty Corp (XOMA)

Report Date: 2026-04-20

Detailed Transactions and Holdings:

• Acquired 10,568 shares of Common Stock (Direct)
  Date: 2026-04-20 | Code: M | equity_swap_involved: false | shares_owned_after: 191,264.00 | transaction_form_type: 4
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-04-20 | Code: H | nature_of_ownership: By 401(k) Plan | shares_owned_after: 295.00
• Holds 0 shares of Depositary Shares - 8.375% Series B Cumulative Stock (Direct)
  Date: 2026-04-20 | Code: H | shares_owned_after: 102,000.00
• Sold 10,568 shares of Performance Stock Units (Derivative)
  Date: 2026-04-20 | Code: M | Expires: 2029-03-11 | equity_swap_involved: false | shares_owned_after: 116,245.00 | transaction_form_type: 4 | Footnotes: F1, F1

Footnotes:

• F1: Each Performance Stock Unit ("PSU") represents a contingent right to receive one share of the Issuer's common stock (the "Common Stock"). The PSUs vest upon the Common Stock achieving a specified price per share, subject to the Reporting Person's continued service to the Issuer through each vesting date.